Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hamilton Thorne to Present to Investors in Toronto on June 27 and in Montreal on June 28

T.HTL

BEVERLY, Mass. and TORONTO, June 20, 2017 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will be presenting to investors at The MicroCap Conference in Toronto on June 27 and at the Espace MicroCap quarterly meeting in Montreal on June 28. 

Toronto June 27, 2017 - David Wolf, President and CEO of Hamilton Thorne will be presenting to investors at The MicroCap Conference at the Sheraton Centre Hotel in Toronto on Tuesday, June 27 at 10:00 and will be available for one-on-one meetings with the investment community during the day of the event.  

Montreal June 28, 2017 - Mr. Wolf will also be presenting to investors at the Espace MicroCap quarterly 5to7 Cocktail meeting at the Bier Markt Montreal on Wednesday, June 28 at approximately 6:00pm.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com/)
Hamilton Thorne is a leading world-wide provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as micro-surgical devices, enabling a wide array of scientific applications and In Vitro Fertilization (IVF) procedures. Its image analysis systems are designed to bring quality, efficiency and reliability to studies of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields.  Hamilton Thorne’s standardized toxicology assays and quality control testing services help to improve outcomes in human IVF clinics. 

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact: David Wolf, President & CEO Hamilton Thorne Ltd. 978-921-2050 ir@hamiltonthorne.com Michael Bruns, CFO Hamilton Thorne Ltd. 978-921-2050 ir@hamiltonthorne.com

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today